Generative AI in a GxP environment: a plain-English starting point

The short answer

Yes, you can use generative AI in a GxP environment, but not everywhere and not on any account. The safe way to start is to draw a clear line between work that touches GxP records or decisions and work that doesn't, keep AI on the right side of that line, and make sure a qualified person reviews anything AI helps produce.

Most life sciences teams are already using AI for emails, summaries and first drafts. The risk isn't that. The risk is when the same tools quietly drift into batch records, deviations, SOPs or study data without anyone deciding that they should.

Why GxP makes AI different

In most businesses, a chatbot getting something slightly wrong is an annoyance. In a GxP setting, the records are the evidence. Regulators expect you to show who did what, when, and why, and that the data hasn't been changed without a trace.

Generative AI doesn't fit neatly into that. The same prompt can give a different answer twice. It can sound confident and be wrong. And on a consumer account, you often can't show where the data went or what happened to it afterwards.

None of that means "never". It means you need to know where AI is being used and keep it away from the places where those weaknesses matter most, at least until you've done the work to control it.

Where the line usually sits

A simple way to think about it is two buckets.

Lower risk, usually outside GxP. Drafting internal emails, summarising public literature, brainstorming, tidying meeting notes that aren't part of a quality record, writing a first draft of a training slide. Mistakes here are easy to catch and don't end up in a regulated record.

Higher risk, GxP-relevant. Anything that creates, changes or interprets a GxP record. Batch records, deviations and CAPAs, SOPs, validation documents, lab data and its analysis, complaint handling, regulatory submissions. Here AI output can affect product quality, patient safety or data integrity.

The grey area is the drift between them. Someone uses AI to summarise a meeting, and the summary ends up attached to a deviation. That is why the line needs to be written down, not just understood.

The rules that already apply

There is no single "AI rule" for GxP yet that answers everything, but you aren't starting from nothing. A few things already apply, and a few more are on the way.

21 CFR Part 11 and EU GMP Annex 11. These cover electronic records, electronic signatures and computerised systems. If an AI tool is used to create or change a regulated record, the same expectations around audit trails, access control and validation apply to it.

ALCOA+ data integrity. Records should be attributable, legible, contemporaneous, original and accurate, plus complete, consistent, enduring and available. A record that was partly written by an AI tool still needs to meet that standard, which mostly comes down to knowing what the tool did and who checked it.

GAMP 5 Second Edition. ISPE's guide on computerised systems was updated in 2022 and added material on AI and machine learning. It is a useful reference for a risk-based approach, and many quality teams already know it.

FDA's draft guidance on AI for regulatory decisions. In January 2025, FDA published draft guidance on using AI to support regulatory decision-making for drugs and biological products. It sets out a risk-based way to judge whether an AI model is credible for a particular use.

EU draft Annex 22 on AI. In July 2025 the European Commission and PIC/S put out a draft GMP annex on artificial intelligence for consultation. As drafted, it takes a cautious line on generative AI in critical GMP uses. Check its current status before relying on it.

The common thread is simple. Know what the tool is used for, judge the risk of that use, control it, and keep a human accountable.

A plain-English starting point

You don't need a big programme to get going. This is the order I would do it in.

1. Find out what's already happening

Before you write rules, find out how your team is actually using AI today. Which tools, on which accounts, for which tasks. A short, no-blame survey and a look at your admin settings will tell you a lot. Our post on finding where your team's data is going walks through a do-it-yourself version.

2. Write down the line

Put the two buckets on one page. What AI can be used for, what it can't, and who to ask about the grey area. Name specific record types, not general principles. "Don't use AI to draft deviation reports" is clearer than "don't use AI for GxP work".

3. Move people onto business accounts

Personal and free accounts are the biggest blind spot. Business plans usually give you admin controls, clearer data terms and a view of who is using what. Pick the approved tools and switch off or block the rest where you can.

4. Make human review a real step

For anything near a GxP record, a qualified person should review AI-assisted work before it's used, and that review should be recorded the same way any other review is. "AI helped" is fine. "Nobody checked" is not.

5. Bring QA in early

Your quality team will need to sign off on how AI fits your quality system. Involving them at the start is faster than asking them to approve something after it has spread. If a use case does belong inside GxP, treat it like any other computerised system and assess it properly.

Why this needs looking after every month

The tools change constantly. Vendors add AI features to software you already pay for, sometimes switched on by default. Staff find new tools. Guidance moves from draft to final. A policy written once and filed away goes out of date fast.

That is the reason we built Managed Safe AI. We keep checking which tools are in use, update the controls as things change, and run a short live training session for your team each month so the rules stay fresh. It usually starts with an AI Safety Check, so you're working from facts about your own team rather than guesses. If you want to see what that involves, here is what an AI Safety Check finds in 10 days.

FAQs

Can we use ChatGPT in a GxP environment?

For non-GxP work like drafting emails or summarising public material, many firms do, ideally on a business account with clear data terms. For anything that creates or changes a GxP record, you would need to assess and control that use first, and most teams start by keeping generative AI out of those records.

Does an AI tool need to be validated?

If it is used for a GxP-relevant purpose, it should be assessed like any other computerised system, using a risk-based approach. If it is only used for work outside GxP, full validation usually isn't expected, but you still need to know where that line sits.

Is AI-generated content a data integrity problem?

It can be. The concern is being able to show who created a record, what changed and who checked it. If AI was involved and nobody can say how, that is a gap against ALCOA+ expectations.

What's the first thing we should do?

Find out how your team is already using AI. Most firms are surprised by how much is going on, and you can't set sensible rules until you know.

Is there a final FDA or EU rule on generative AI in GMP?

Not one that covers everything. FDA's January 2025 guidance was published as a draft, and the EU's Annex 22 was released for consultation in July 2025. Check the current status of both, and talk to your quality and regulatory advisers about how they apply to you.

*This post is general information, not legal or regulatory advice. Talk to your quality, regulatory or legal advisers about your own situation.*